These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1898799)

  • 1. Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients.
    Saxon RR; Klein JS; Bar MH; Blanc P; Gamsu G; Webb WR; Aronson FR
    AJR Am J Roentgenol; 1991 Feb; 156(2):281-5. PubMed ID: 1898799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular leak syndrome associated with interleukin-2: chest radiographic manifestations.
    Mann H; Ward JH; Samlowski WE
    Radiology; 1990 Jul; 176(1):191-4. PubMed ID: 2353090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary edema as a complication of interleukin-2 therapy.
    Conant EF; Fox KR; Miller WT
    AJR Am J Roentgenol; 1989 Apr; 152(4):749-52. PubMed ID: 2784257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 therapy for advanced renal cell carcinoma: radiographic evaluation of response and complications.
    Davis SD; Berkmen YM; Wang JC
    Radiology; 1990 Oct; 177(1):127-31. PubMed ID: 2399311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest roentgenographic abnormalities in IL-2 recipients. Incidence and correlation with clinical parameters.
    Vogelzang PJ; Bloom SM; Mier JW; Atkins MB
    Chest; 1992 Mar; 101(3):746-52. PubMed ID: 1541142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2.
    Quan WD; Khan N; Ramirez M; Taylor WC; Quan F; Vinogradov M; Walker P
    Cancer Biother Radiopharm; 2005 Apr; 20(2):151-4. PubMed ID: 15869448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiologic characteristics of the thorax during therapy with interleukin-2].
    Morassut S; Balestreri L; Galligioni E; Coran F; Sacco C
    Radiol Med; 1992 Oct; 84(4):368-71. PubMed ID: 1455017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.
    Kilbourn RG; Fonseca GA; Trissel LA; Griffith OW
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S21-30. PubMed ID: 10685654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary edema during IL-2 therapy: combined effect of increased permeability and hydrostatic pressure.
    Berthiaume Y; Boiteau P; Fick G; Kloiber R; Sinclair GD; Fong C; Poon MC; Lafrenière R
    Am J Respir Crit Care Med; 1995 Jul; 152(1):329-35. PubMed ID: 7599842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2.
    Khong B; Lawson BO; Ma J; McGovern C; Van Atta JK; Ray A; Khong HT
    BMC Cancer; 2018 Oct; 18(1):1007. PubMed ID: 30342473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary toxicity of recombinant interleukin-2 plus lymphokine-activated killer cell therapy.
    Villani F; Galimberti M; Rizzi M; Manzi R
    Eur Respir J; 1993 Jun; 6(6):828-33. PubMed ID: 8339802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of renal cell carcinoma with ascites after interleukin-2 therapy].
    Kobori G; Maegawa M; Ushida H; Maekawa S; Inoue K; Kaneko Y; Ohmori K; Nishimura K
    Hinyokika Kiyo; 2002 Jul; 48(7):455-7. PubMed ID: 12229188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations.
    Kanerva M; Paakkala A; Mustonen J; Paakkala T; Lahtela J; Pasternack A
    Clin Nephrol; 1996 Dec; 46(6):369-78. PubMed ID: 8982552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients.
    Aberle DR; Wiener-Kronish JP; Webb WR; Matthay MA
    Radiology; 1988 Jul; 168(1):73-9. PubMed ID: 3380985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiographic and computed tomographic manifestations of chest in patients with acute chlorine gas poisoning].
    Liu ZJ; Huang DJ; Wang ZQ; Wang ZG; Chang SH; Wu ZC
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(39):2740-4. PubMed ID: 21162908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2.
    Mittelman A; Savona S; Gafney E; Penichet KO; Lin BY; Levitt D; Ahmed T; Arlin ZA; Baskind P; Needleman D
    J Biol Response Mod; 1989 Oct; 8(5):468-78. PubMed ID: 2795092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor.
    McDermott DF; Trehu EG; Mier JW; Sorce D; Rand W; Ronayne L; Kappler K; Clancy M; Klempner M; Atkins MB
    Clin Cancer Res; 1998 May; 4(5):1203-13. PubMed ID: 9607578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
    Quan W; Ramirez M; Taylor C; Quan F; Vinogradov M; Walker P
    Cancer Biother Radiopharm; 2005 Feb; 20(1):11-5. PubMed ID: 15778574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.
    Budd GT; Osgood B; Barna B; Boyett JM; Finke J; Medendorp SV; Murthy S; Novak C; Sergi J; Tubbs R
    Cancer Res; 1989 Nov; 49(22):6432-6. PubMed ID: 2804986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.